Fingerprint
Dive into the research topics of 'Lack of drug interaction between the migraine drug MAP0004 (orally inhaled dihydroergotamine) and a CYP3A4 inhibitor in humans'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Lack of drug interaction between the migraine drug MAP0004 (orally inhaled dihydroergotamine) and a CYP3A4 inhibitor in humans
D. Kellerman, S. Kori, A. Forst, J. Chang, S. Febbraro, L. Wutann, T. Thomas, G. Taylor, D. W. Dodick
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations